Deep Response in Multiple Myeloma: A Critical Review

DSpace/Manakin Repository

Deep Response in Multiple Myeloma: A Critical Review

Citable link to this page


Title: Deep Response in Multiple Myeloma: A Critical Review
Author: Fulciniti, Mariateresa; Munshi, Nikhil C.; Martinez-Lopez, Joaquin

Note: Order does not necessarily reflect citation order of authors.

Citation: Fulciniti, Mariateresa, Nikhil C. Munshi, and Joaquin Martinez-Lopez. 2015. “Deep Response in Multiple Myeloma: A Critical Review.” BioMed Research International 2015 (1): 832049. doi:10.1155/2015/832049.
Full Text & Related Files:
Abstract: Novel and more effective treatment strategies against multiple myeloma (MM) have significantly prolonged patients' survival and raised interest in the depth of response and its association with clinical outcome. Minimal residual disease (MRD) has emerged as one of the most relevant prognostic factors in MM and should be included in a new definition of complete response (CR). Although further standardization is still required, MRD monitoring should be applied in prospective clinical trials as a sensitive tool to compare and evaluate the efficacy of different treatment strategies, particularly in the consolidation and maintenance settings, and implement individualized therapy-monitoring approaches. Here, we review current definition of deep response in MM, advantages and limitations of current MRD assessment assays, clinical evidences for MRD monitoring as a prognostic tool for therapeutic decisions in MM, and challenges to develop uniform criteria for MRD monitoring.
Published Version: doi:10.1155/2015/832049
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search